Canlyniadau Chwilio - Danilo Fliser

Mireinio'r Canlyniadau
  1. 1
    Clinical relevance of FGF-23 in chronic kidney disease

    Clinical relevance of FGF-23 in chronic kidney disease gan Sarah Seiler, Gunnar H. Heine, Danilo Fliser

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Calcium and phosphate impact cardiovascular risk

    Calcium and phosphate impact cardiovascular risk gan Gunnar H. Heine, Masaomi Nangaku, Danilo Fliser

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    FGF-23: the rise of a novel cardiovascular risk marker in CKD

    FGF-23: the rise of a novel cardiovascular risk marker in CKD gan Gunnar H. Heine, Sarah Seiler, Danilo Fliser

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure

    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure gan Danilo Fliser, M. Schröter, Monika Neubeck, Eberhard Ritz

    Cyhoeddwyd 1994
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Innate immunity in CKD-associated vascular diseases

    Innate immunity in CKD-associated vascular diseases gan Stephen Zewinger, Timo Schumann, Danilo Fliser, Thimoteus Speer

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Renal functional reserve in healthy elderly subjects.

    Renal functional reserve in healthy elderly subjects. gan Danilo Fliser, M. Zeier, Rainer Nowack, Eberhard Ritz

    Cyhoeddwyd 1993
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Renal findings in patients with short-term type 2 diabetes.

    Renal findings in patients with short-term type 2 diabetes. gan Christine K. Keller, K. Bergis, Danilo Fliser, Eberhard Ritz

    Cyhoeddwyd 1996
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Cardiovascular Disease in Chronic Kidney Disease

    Cardiovascular Disease in Chronic Kidney Disease gan Joachim Jankowski, Jürgen Floege, Danilo Fliser, Michael Böhm, Nikolaus Marx

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease

    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease gan Christof Ulrich, Gunnar H. Heine, Eric Seibert, Danilo Fliser, Matthias Girndt

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes

    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes gan Danilo Fliser, Kathrin-Kristin Wagner, Astrid Loos, Dimitrios Tsikas, Hermann Haller

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Renal function in the elderly: Impact of hypertension and cardiac function

    Renal function in the elderly: Impact of hypertension and cardiac function gan Danilo Fliser, Edward Franek, Markus Joest, Stefan Block, Ernst Mutschler, Eberhard Ritz

    Cyhoeddwyd 1997
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis

    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis gan Sascha David, P. Kumpers, V. Seidler, Frank Biertz, Hermann Haller, Danilo Fliser

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Lipoproteins in chronic kidney disease: from bench to bedside

    Lipoproteins in chronic kidney disease: from bench to bedside gan Thimoteus Speer, Paul M. Ridker, Arnold von Eckardstein, Stefan Schunk, Danilo Fliser

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment gan Sarah Seiler, B Reichart, Daniel Röth, Eric Seibert, Danilo Fliser, Gunnar H. Heine

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction

    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction gan Matthias Klingele, Theresa Stadler, Danilo Fliser, Thimoteus Speer, Heinrich V. Groesdonk, Alexander Raddatz

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study

    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study gan Barbara Kollerits, Danilo Fliser, Iris M. Heid, Eberhard Ritz, Florian Kronenberg, for the MMKD Study Group

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Stimulation of Endothelial Progenitor Cells

    Stimulation of Endothelial Progenitor Cells gan Ferdinand H. Bahlmann, Kirsten de Groot, Ottfried Mueller, Barbara Hertel, Hermann Haller, Danilo Fliser

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Coadministration of albumin and furosemide in patients with the nephrotic syndrome

    Coadministration of albumin and furosemide in patients with the nephrotic syndrome gan Danilo Fliser, Ines Zurbrüggen, E. Mutschler, Irene Bischoff, Jürg Nussberger, Edward Franek, Eberhard Ritz

    Cyhoeddwyd 1999
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis gan Jan T. Kielstein, Shelley R. Salpeter, Stefanie M. Bode-Boeger, John P. Cooke, Danilo Fliser

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease

    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease gan Bjoern Becker, Florian Kronenberg, Jan T. Kielstein, Hermann Haller, Christian Morath, Eberhard Ritz, Danilo Fliser

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: